← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2007Last known activity
Nov 1, 2023
Timeline
2000s
- Jun 1, 2003
Translational Drug Development— Founded
Drugs by trial phase (21 distinct, 15 trials)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Studied for
- Basal Cell Carcinoma
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Squamous Cell
- Cholangiocarcinoma
- Colorectal Neoplasms
- Esophageal Neoplasms
- Hypoxia
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Neoplasm Metastasis
- Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
Recent trials (17)
- NCT06086522CollaboratorPhase 1Nov 1, 2023
- NCT05651022CollaboratorPhase 1/Phase 2Feb 28, 2023
- NCT05163080CollaboratorPhase 2Nov 18, 2021
- NCT04880863CollaboratorPhase 2Jul 29, 2021
- NCT04676633CollaboratorPhase 1Mar 1, 2021
- NCT04291664CollaboratorPhase 1Jan 31, 2020
- NCT03775525CollaboratorPhase 1Mar 1, 2019
- NCT03775525Study directorPhase 1Mar 1, 2019
- NCT03854110CollaboratorPhase 1/Phase 2Jan 14, 2019
- NCT03199586CollaboratorPhase 1Sep 1, 2017
- NCT03129139CollaboratorPhase 1Aug 1, 2017
- NCT02056782CollaboratorPhase 1Dec 1, 2013
- NCT01893801CollaboratorPhase 1/Phase 2May 1, 2013
- NCT01461915CollaboratorPhase 2Nov 1, 2011
- NCT00954876Lead sponsorPhase 2Aug 1, 2009
Details
- Founded
- Scottsdale, AZ, US Jun 1, 2003
- Last known activity
- Nov 1, 2023
Notes
CRO